[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global EGFR-TKI for Advanced NSCLC Market 2023 by Company, Regions, Type and Application, Forecast to 2029

February 2023 | 86 pages | ID: GE79D578AE45EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can benefit NSCLC patients harbouring EGFR mutations.

According to our (Global Info Research) latest study, the global EGFR-TKI for Advanced NSCLC market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global EGFR-TKI for Advanced NSCLC market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global EGFR-TKI for Advanced NSCLC market size and forecasts, in consumption value ($ Million), 2018-2029

Global EGFR-TKI for Advanced NSCLC market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global EGFR-TKI for Advanced NSCLC market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global EGFR-TKI for Advanced NSCLC market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for EGFR-TKI for Advanced NSCLC

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global EGFR-TKI for Advanced NSCLC market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Henan DaKen Chemical, Capot Chemical Co.,Ltd., Chemwill Asia Co.,Ltd., MSN Labs and Sun Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

EGFR-TKI for Advanced NSCLC market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Gefitinib
  • Erlotinib
  • Afatinib
Market segment by Application
  • Combination Therapy
  • Mono Therapy
Market segment by players, this report covers
  • Henan DaKen Chemical
  • Capot Chemical Co.,Ltd.
  • Chemwill Asia Co.,Ltd.
  • MSN Labs
  • Sun Pharma
  • Amadis Chemical
  • Chongqing Chemdad Co., Ltd
  • Mylan
  • Alchem Pharmtech,Inc.
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe EGFR-TKI for Advanced NSCLC product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of EGFR-TKI for Advanced NSCLC, with revenue, gross margin and global market share of EGFR-TKI for Advanced NSCLC from 2018 to 2023.

Chapter 3, the EGFR-TKI for Advanced NSCLC competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and EGFR-TKI for Advanced NSCLC market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of EGFR-TKI for Advanced NSCLC.

Chapter 13, to describe EGFR-TKI for Advanced NSCLC research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of EGFR-TKI for Advanced NSCLC
1.2 Market Estimation Caveats and Base Year
1.3 Classification of EGFR-TKI for Advanced NSCLC by Type
  1.3.1 Overview: Global EGFR-TKI for Advanced NSCLC Market Size by Type: 2018 Versus 2022 Versus 2029
  1.3.2 Global EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Type in 2022
  1.3.3 Gefitinib
  1.3.4 Erlotinib
  1.3.5 Afatinib
1.4 Global EGFR-TKI for Advanced NSCLC Market by Application
  1.4.1 Overview: Global EGFR-TKI for Advanced NSCLC Market Size by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Combination Therapy
  1.4.3 Mono Therapy
1.5 Global EGFR-TKI for Advanced NSCLC Market Size & Forecast
1.6 Global EGFR-TKI for Advanced NSCLC Market Size and Forecast by Region
  1.6.1 Global EGFR-TKI for Advanced NSCLC Market Size by Region: 2018 VS 2022 VS 2029
  1.6.2 Global EGFR-TKI for Advanced NSCLC Market Size by Region, (2018-2029)
  1.6.3 North America EGFR-TKI for Advanced NSCLC Market Size and Prospect (2018-2029)
  1.6.4 Europe EGFR-TKI for Advanced NSCLC Market Size and Prospect (2018-2029)
  1.6.5 Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size and Prospect (2018-2029)
  1.6.6 South America EGFR-TKI for Advanced NSCLC Market Size and Prospect (2018-2029)
  1.6.7 Middle East and Africa EGFR-TKI for Advanced NSCLC Market Size and Prospect (2018-2029)

2 COMPANY PROFILES

2.1 Henan DaKen Chemical
  2.1.1 Henan DaKen Chemical Details
  2.1.2 Henan DaKen Chemical Major Business
  2.1.3 Henan DaKen Chemical EGFR-TKI for Advanced NSCLC Product and Solutions
  2.1.4 Henan DaKen Chemical EGFR-TKI for Advanced NSCLC Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 Henan DaKen Chemical Recent Developments and Future Plans
2.2 Capot Chemical Co.,Ltd.
  2.2.1 Capot Chemical Co.,Ltd. Details
  2.2.2 Capot Chemical Co.,Ltd. Major Business
  2.2.3 Capot Chemical Co.,Ltd. EGFR-TKI for Advanced NSCLC Product and Solutions
  2.2.4 Capot Chemical Co.,Ltd. EGFR-TKI for Advanced NSCLC Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 Capot Chemical Co.,Ltd. Recent Developments and Future Plans
2.3 Chemwill Asia Co.,Ltd.
  2.3.1 Chemwill Asia Co.,Ltd. Details
  2.3.2 Chemwill Asia Co.,Ltd. Major Business
  2.3.3 Chemwill Asia Co.,Ltd. EGFR-TKI for Advanced NSCLC Product and Solutions
  2.3.4 Chemwill Asia Co.,Ltd. EGFR-TKI for Advanced NSCLC Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 Chemwill Asia Co.,Ltd. Recent Developments and Future Plans
2.4 MSN Labs
  2.4.1 MSN Labs Details
  2.4.2 MSN Labs Major Business
  2.4.3 MSN Labs EGFR-TKI for Advanced NSCLC Product and Solutions
  2.4.4 MSN Labs EGFR-TKI for Advanced NSCLC Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 MSN Labs Recent Developments and Future Plans
2.5 Sun Pharma
  2.5.1 Sun Pharma Details
  2.5.2 Sun Pharma Major Business
  2.5.3 Sun Pharma EGFR-TKI for Advanced NSCLC Product and Solutions
  2.5.4 Sun Pharma EGFR-TKI for Advanced NSCLC Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 Sun Pharma Recent Developments and Future Plans
2.6 Amadis Chemical
  2.6.1 Amadis Chemical Details
  2.6.2 Amadis Chemical Major Business
  2.6.3 Amadis Chemical EGFR-TKI for Advanced NSCLC Product and Solutions
  2.6.4 Amadis Chemical EGFR-TKI for Advanced NSCLC Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 Amadis Chemical Recent Developments and Future Plans
2.7 Chongqing Chemdad Co., Ltd
  2.7.1 Chongqing Chemdad Co., Ltd Details
  2.7.2 Chongqing Chemdad Co., Ltd Major Business
  2.7.3 Chongqing Chemdad Co., Ltd EGFR-TKI for Advanced NSCLC Product and Solutions
  2.7.4 Chongqing Chemdad Co., Ltd EGFR-TKI for Advanced NSCLC Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 Chongqing Chemdad Co., Ltd Recent Developments and Future Plans
2.8 Mylan
  2.8.1 Mylan Details
  2.8.2 Mylan Major Business
  2.8.3 Mylan EGFR-TKI for Advanced NSCLC Product and Solutions
  2.8.4 Mylan EGFR-TKI for Advanced NSCLC Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 Mylan Recent Developments and Future Plans
2.9 Alchem Pharmtech,Inc.
  2.9.1 Alchem Pharmtech,Inc. Details
  2.9.2 Alchem Pharmtech,Inc. Major Business
  2.9.3 Alchem Pharmtech,Inc. EGFR-TKI for Advanced NSCLC Product and Solutions
  2.9.4 Alchem Pharmtech,Inc. EGFR-TKI for Advanced NSCLC Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 Alchem Pharmtech,Inc. Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global EGFR-TKI for Advanced NSCLC Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
  3.2.1 Market Share of EGFR-TKI for Advanced NSCLC by Company Revenue
  3.2.2 Top 3 EGFR-TKI for Advanced NSCLC Players Market Share in 2022
  3.2.3 Top 6 EGFR-TKI for Advanced NSCLC Players Market Share in 2022
3.3 EGFR-TKI for Advanced NSCLC Market: Overall Company Footprint Analysis
  3.3.1 EGFR-TKI for Advanced NSCLC Market: Region Footprint
  3.3.2 EGFR-TKI for Advanced NSCLC Market: Company Product Type Footprint
  3.3.3 EGFR-TKI for Advanced NSCLC Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global EGFR-TKI for Advanced NSCLC Consumption Value and Market Share by Type (2018-2023)
4.2 Global EGFR-TKI for Advanced NSCLC Market Forecast by Type (2024-2029)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Application (2018-2023)
5.2 Global EGFR-TKI for Advanced NSCLC Market Forecast by Application (2024-2029)

6 NORTH AMERICA

6.1 North America EGFR-TKI for Advanced NSCLC Consumption Value by Type (2018-2029)
6.2 North America EGFR-TKI for Advanced NSCLC Consumption Value by Application (2018-2029)
6.3 North America EGFR-TKI for Advanced NSCLC Market Size by Country
  6.3.1 North America EGFR-TKI for Advanced NSCLC Consumption Value by Country (2018-2029)
  6.3.2 United States EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)
  6.3.3 Canada EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)
  6.3.4 Mexico EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)

7 EUROPE

7.1 Europe EGFR-TKI for Advanced NSCLC Consumption Value by Type (2018-2029)
7.2 Europe EGFR-TKI for Advanced NSCLC Consumption Value by Application (2018-2029)
7.3 Europe EGFR-TKI for Advanced NSCLC Market Size by Country
  7.3.1 Europe EGFR-TKI for Advanced NSCLC Consumption Value by Country (2018-2029)
  7.3.2 Germany EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)
  7.3.3 France EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)
  7.3.4 United Kingdom EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)
  7.3.5 Russia EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)
  7.3.6 Italy EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)

8 ASIA-PACIFIC

8.1 Asia-Pacific EGFR-TKI for Advanced NSCLC Consumption Value by Type (2018-2029)
8.2 Asia-Pacific EGFR-TKI for Advanced NSCLC Consumption Value by Application (2018-2029)
8.3 Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Region
  8.3.1 Asia-Pacific EGFR-TKI for Advanced NSCLC Consumption Value by Region (2018-2029)
  8.3.2 China EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)
  8.3.3 Japan EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)
  8.3.4 South Korea EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)
  8.3.5 India EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)
  8.3.6 Southeast Asia EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)
  8.3.7 Australia EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)

9 SOUTH AMERICA

9.1 South America EGFR-TKI for Advanced NSCLC Consumption Value by Type (2018-2029)
9.2 South America EGFR-TKI for Advanced NSCLC Consumption Value by Application (2018-2029)
9.3 South America EGFR-TKI for Advanced NSCLC Market Size by Country
  9.3.1 South America EGFR-TKI for Advanced NSCLC Consumption Value by Country (2018-2029)
  9.3.2 Brazil EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)
  9.3.3 Argentina EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa EGFR-TKI for Advanced NSCLC Consumption Value by Type (2018-2029)
10.2 Middle East & Africa EGFR-TKI for Advanced NSCLC Consumption Value by Application (2018-2029)
10.3 Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Country
  10.3.1 Middle East & Africa EGFR-TKI for Advanced NSCLC Consumption Value by Country (2018-2029)
  10.3.2 Turkey EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)
  10.3.3 Saudi Arabia EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)
  10.3.4 UAE EGFR-TKI for Advanced NSCLC Market Size and Forecast (2018-2029)

11 MARKET DYNAMICS

11.1 EGFR-TKI for Advanced NSCLC Market Drivers
11.2 EGFR-TKI for Advanced NSCLC Market Restraints
11.3 EGFR-TKI for Advanced NSCLC Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
  11.5.1 Influence of COVID-19
  11.5.2 Influence of Russia-Ukraine War

12 INDUSTRY CHAIN ANALYSIS

12.1 EGFR-TKI for Advanced NSCLC Industry Chain
12.2 EGFR-TKI for Advanced NSCLC Upstream Analysis
12.3 EGFR-TKI for Advanced NSCLC Midstream Analysis
12.4 EGFR-TKI for Advanced NSCLC Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

LIST OF TABLES

Table 1. Global EGFR-TKI for Advanced NSCLC Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global EGFR-TKI for Advanced NSCLC Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global EGFR-TKI for Advanced NSCLC Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global EGFR-TKI for Advanced NSCLC Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Henan DaKen Chemical Company Information, Head Office, and Major Competitors
Table 6. Henan DaKen Chemical Major Business
Table 7. Henan DaKen Chemical EGFR-TKI for Advanced NSCLC Product and Solutions
Table 8. Henan DaKen Chemical EGFR-TKI for Advanced NSCLC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Henan DaKen Chemical Recent Developments and Future Plans
Table 10. Capot Chemical Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 11. Capot Chemical Co.,Ltd. Major Business
Table 12. Capot Chemical Co.,Ltd. EGFR-TKI for Advanced NSCLC Product and Solutions
Table 13. Capot Chemical Co.,Ltd. EGFR-TKI for Advanced NSCLC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Capot Chemical Co.,Ltd. Recent Developments and Future Plans
Table 15. Chemwill Asia Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 16. Chemwill Asia Co.,Ltd. Major Business
Table 17. Chemwill Asia Co.,Ltd. EGFR-TKI for Advanced NSCLC Product and Solutions
Table 18. Chemwill Asia Co.,Ltd. EGFR-TKI for Advanced NSCLC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Chemwill Asia Co.,Ltd. Recent Developments and Future Plans
Table 20. MSN Labs Company Information, Head Office, and Major Competitors
Table 21. MSN Labs Major Business
Table 22. MSN Labs EGFR-TKI for Advanced NSCLC Product and Solutions
Table 23. MSN Labs EGFR-TKI for Advanced NSCLC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. MSN Labs Recent Developments and Future Plans
Table 25. Sun Pharma Company Information, Head Office, and Major Competitors
Table 26. Sun Pharma Major Business
Table 27. Sun Pharma EGFR-TKI for Advanced NSCLC Product and Solutions
Table 28. Sun Pharma EGFR-TKI for Advanced NSCLC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Sun Pharma Recent Developments and Future Plans
Table 30. Amadis Chemical Company Information, Head Office, and Major Competitors
Table 31. Amadis Chemical Major Business
Table 32. Amadis Chemical EGFR-TKI for Advanced NSCLC Product and Solutions
Table 33. Amadis Chemical EGFR-TKI for Advanced NSCLC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Amadis Chemical Recent Developments and Future Plans
Table 35. Chongqing Chemdad Co., Ltd Company Information, Head Office, and Major Competitors
Table 36. Chongqing Chemdad Co., Ltd Major Business
Table 37. Chongqing Chemdad Co., Ltd EGFR-TKI for Advanced NSCLC Product and Solutions
Table 38. Chongqing Chemdad Co., Ltd EGFR-TKI for Advanced NSCLC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Chongqing Chemdad Co., Ltd Recent Developments and Future Plans
Table 40. Mylan Company Information, Head Office, and Major Competitors
Table 41. Mylan Major Business
Table 42. Mylan EGFR-TKI for Advanced NSCLC Product and Solutions
Table 43. Mylan EGFR-TKI for Advanced NSCLC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Mylan Recent Developments and Future Plans
Table 45. Alchem Pharmtech,Inc. Company Information, Head Office, and Major Competitors
Table 46. Alchem Pharmtech,Inc. Major Business
Table 47. Alchem Pharmtech,Inc. EGFR-TKI for Advanced NSCLC Product and Solutions
Table 48. Alchem Pharmtech,Inc. EGFR-TKI for Advanced NSCLC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Alchem Pharmtech,Inc. Recent Developments and Future Plans
Table 50. Global EGFR-TKI for Advanced NSCLC Revenue (USD Million) by Players (2018-2023)
Table 51. Global EGFR-TKI for Advanced NSCLC Revenue Share by Players (2018-2023)
Table 52. Breakdown of EGFR-TKI for Advanced NSCLC by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in EGFR-TKI for Advanced NSCLC, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 54. Head Office of Key EGFR-TKI for Advanced NSCLC Players
Table 55. EGFR-TKI for Advanced NSCLC Market: Company Product Type Footprint
Table 56. EGFR-TKI for Advanced NSCLC Market: Company Product Application Footprint
Table 57. EGFR-TKI for Advanced NSCLC New Market Entrants and Barriers to Market Entry
Table 58. EGFR-TKI for Advanced NSCLC Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global EGFR-TKI for Advanced NSCLC Consumption Value (USD Million) by Type (2018-2023)
Table 60. Global EGFR-TKI for Advanced NSCLC Consumption Value Share by Type (2018-2023)
Table 61. Global EGFR-TKI for Advanced NSCLC Consumption Value Forecast by Type (2024-2029)
Table 62. Global EGFR-TKI for Advanced NSCLC Consumption Value by Application (2018-2023)
Table 63. Global EGFR-TKI for Advanced NSCLC Consumption Value Forecast by Application (2024-2029)
Table 64. North America EGFR-TKI for Advanced NSCLC Consumption Value by Type (2018-2023) & (USD Million)
Table 65. North America EGFR-TKI for Advanced NSCLC Consumption Value by Type (2024-2029) & (USD Million)
Table 66. North America EGFR-TKI for Advanced NSCLC Consumption Value by Application (2018-2023) & (USD Million)
Table 67. North America EGFR-TKI for Advanced NSCLC Consumption Value by Application (2024-2029) & (USD Million)
Table 68. North America EGFR-TKI for Advanced NSCLC Consumption Value by Country (2018-2023) & (USD Million)
Table 69. North America EGFR-TKI for Advanced NSCLC Consumption Value by Country (2024-2029) & (USD Million)
Table 70. Europe EGFR-TKI for Advanced NSCLC Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Europe EGFR-TKI for Advanced NSCLC Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Europe EGFR-TKI for Advanced NSCLC Consumption Value by Application (2018-2023) & (USD Million)
Table 73. Europe EGFR-TKI for Advanced NSCLC Consumption Value by Application (2024-2029) & (USD Million)
Table 74. Europe EGFR-TKI for Advanced NSCLC Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe EGFR-TKI for Advanced NSCLC Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific EGFR-TKI for Advanced NSCLC Consumption Value by Type (2018-2023) & (USD Million)
Table 77. Asia-Pacific EGFR-TKI for Advanced NSCLC Consumption Value by Type (2024-2029) & (USD Million)
Table 78. Asia-Pacific EGFR-TKI for Advanced NSCLC Consumption Value by Application (2018-2023) & (USD Million)
Table 79. Asia-Pacific EGFR-TKI for Advanced NSCLC Consumption Value by Application (2024-2029) & (USD Million)
Table 80. Asia-Pacific EGFR-TKI for Advanced NSCLC Consumption Value by Region (2018-2023) & (USD Million)
Table 81. Asia-Pacific EGFR-TKI for Advanced NSCLC Consumption Value by Region (2024-2029) & (USD Million)
Table 82. South America EGFR-TKI for Advanced NSCLC Consumption Value by Type (2018-2023) & (USD Million)
Table 83. South America EGFR-TKI for Advanced NSCLC Consumption Value by Type (2024-2029) & (USD Million)
Table 84. South America EGFR-TKI for Advanced NSCLC Consumption Value by Application (2018-2023) & (USD Million)
Table 85. South America EGFR-TKI for Advanced NSCLC Consumption Value by Application (2024-2029) & (USD Million)
Table 86. South America EGFR-TKI for Advanced NSCLC Consumption Value by Country (2018-2023) & (USD Million)
Table 87. South America EGFR-TKI for Advanced NSCLC Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Middle East & Africa EGFR-TKI for Advanced NSCLC Consumption Value by Type (2018-2023) & (USD Million)
Table 89. Middle East & Africa EGFR-TKI for Advanced NSCLC Consumption Value by Type (2024-2029) & (USD Million)
Table 90. Middle East & Africa EGFR-TKI for Advanced NSCLC Consumption Value by Application (2018-2023) & (USD Million)
Table 91. Middle East & Africa EGFR-TKI for Advanced NSCLC Consumption Value by Application (2024-2029) & (USD Million)
Table 92. Middle East & Africa EGFR-TKI for Advanced NSCLC Consumption Value by Country (2018-2023) & (USD Million)
Table 93. Middle East & Africa EGFR-TKI for Advanced NSCLC Consumption Value by Country (2024-2029) & (USD Million)
Table 94. EGFR-TKI for Advanced NSCLC Raw Material
Table 95. Key Suppliers of EGFR-TKI for Advanced NSCLC Raw Materials

LIST OF FIGURES

Figure 1. EGFR-TKI for Advanced NSCLC Picture
Figure 2. Global EGFR-TKI for Advanced NSCLC Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Type in 2022
Figure 4. Gefitinib
Figure 5. Erlotinib
Figure 6. Afatinib
Figure 7. Global EGFR-TKI for Advanced NSCLC Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Application in 2022
Figure 9. Combination Therapy Picture
Figure 10. Mono Therapy Picture
Figure 11. Global EGFR-TKI for Advanced NSCLC Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global EGFR-TKI for Advanced NSCLC Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market EGFR-TKI for Advanced NSCLC Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Region (2018-2029)
Figure 15. Global EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Region in 2022
Figure 16. North America EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 19. South America EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 21. Global EGFR-TKI for Advanced NSCLC Revenue Share by Players in 2022
Figure 22. EGFR-TKI for Advanced NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players EGFR-TKI for Advanced NSCLC Market Share in 2022
Figure 24. Global Top 6 Players EGFR-TKI for Advanced NSCLC Market Share in 2022
Figure 25. Global EGFR-TKI for Advanced NSCLC Consumption Value Share by Type (2018-2023)
Figure 26. Global EGFR-TKI for Advanced NSCLC Market Share Forecast by Type (2024-2029)
Figure 27. Global EGFR-TKI for Advanced NSCLC Consumption Value Share by Application (2018-2023)
Figure 28. Global EGFR-TKI for Advanced NSCLC Market Share Forecast by Application (2024-2029)
Figure 29. North America EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Type (2018-2029)
Figure 30. North America EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Application (2018-2029)
Figure 31. North America EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Country (2018-2029)
Figure 32. United States EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 39. France EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Region (2018-2029)
Figure 46. China EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 49. India EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 52. South America EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Type (2018-2029)
Figure 53. South America EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Application (2018-2029)
Figure 54. South America EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa EGFR-TKI for Advanced NSCLC Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE EGFR-TKI for Advanced NSCLC Consumption Value (2018-2029) & (USD Million)
Figure 63. EGFR-TKI for Advanced NSCLC Market Drivers
Figure 64. EGFR-TKI for Advanced NSCLC Market Restraints
Figure 65. EGFR-TKI for Advanced NSCLC Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of EGFR-TKI for Advanced NSCLC in 2022
Figure 68. Manufacturing Process Analysis of EGFR-TKI for Advanced NSCLC
Figure 69. EGFR-TKI for Advanced NSCLC Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source


More Publications